Inferior Vena Cava Filter Retrieval Trends: A Single-Center Experience

Recognition of the adverse events of inferior vena cava filters (VCFs) has prompted the Food and Drug Administration (FDA) to issue safety warnings (2010 and 2014), advocating for removal, once the risk of pulmonary embolism has abated. Despite an initial increase in retrieval rates, these remain lo...

Full description

Bibliographic Details
Main Authors: Filip Ionescu, Nwabundo Anusim, Eva Ma, Lihua Qu, LeAnn M. Blankenship, Michael Stender, Ishmael Jaiyesimi
Format: Article
Language:English
Published: Georg Thieme Verlag KG 2021-01-01
Series:TH Open
Subjects:
Online Access:http://www.thieme-connect.de/DOI/DOI?10.1055/s-0040-1722707
_version_ 1819160305427546112
author Filip Ionescu
Nwabundo Anusim
Eva Ma
Lihua Qu
LeAnn M. Blankenship
Michael Stender
Ishmael Jaiyesimi
author_facet Filip Ionescu
Nwabundo Anusim
Eva Ma
Lihua Qu
LeAnn M. Blankenship
Michael Stender
Ishmael Jaiyesimi
author_sort Filip Ionescu
collection DOAJ
description Recognition of the adverse events of inferior vena cava filters (VCFs) has prompted the Food and Drug Administration (FDA) to issue safety warnings (2010 and 2014), advocating for removal, once the risk of pulmonary embolism has abated. Despite an initial increase in retrieval rates, these remain low (25–30% at 1 year in 2014). We retrospectively investigated retrieval trends in adults with VCFs placed between 2015 and 2018 at a single institution. The rate of retrievable VCF removal accounting for the competing risk of death was the main outcome. There were 494 VCFs placed (305 retrievable). The cumulative incidence of retrieval remained low (21% at 1 year), even after the second FDA warning (2014). Patients who resumed anticoagulation (AC) at any time were more likely to have retrieval (hazard ratio [HR] = 3.6, p < 0.01) and had higher retrieval rates at every time point (31.4 vs. 7.6% at 1 year). Advanced age (HR = 0.98 per year, p = 0.004), stroke (HR = 0.28, p = 0.028), and active malignancy (HR = 0.42, p = 0.006) predicted nonretrieval. Device-related complications were infrequent (<1%) but thrombotic complications occurred early and were more common for nonretrieved VCFs (17 vs. 12%, p = 0.29). Revision of guidelines to recommend active surveillance for the ability to tolerate AC in the immediate postimplantation period may improve retrieval rates.
first_indexed 2024-12-22T16:54:20Z
format Article
id doaj.art-77903afd6bbb470f8e538e689ebd9c5f
institution Directory Open Access Journal
issn 2512-9465
language English
last_indexed 2024-12-22T16:54:20Z
publishDate 2021-01-01
publisher Georg Thieme Verlag KG
record_format Article
series TH Open
spelling doaj.art-77903afd6bbb470f8e538e689ebd9c5f2022-12-21T18:19:29ZengGeorg Thieme Verlag KGTH Open2512-94652021-01-010501e73e8010.1055/s-0040-1722707Inferior Vena Cava Filter Retrieval Trends: A Single-Center ExperienceFilip Ionescu0Nwabundo Anusim1Eva Ma2Lihua Qu3LeAnn M. Blankenship4Michael Stender5Ishmael Jaiyesimi6Department of Internal Medicine, Beaumont Health System, Royal Oak, Michigan, United StatesDepartment of Hematology-Oncology, Beaumont Health System, Royal Oak, Michigan, United StatesDepartment of Internal Medicine, Beaumont Health System, Royal Oak, Michigan, United StatesBeaumont Health Research Institute, Royal Oak, Michigan, United StatesDepartment of Hematology-Oncology, Beaumont Health System, Royal Oak, Michigan, United StatesDepartment of Hematology-Oncology, Beaumont Health System, Royal Oak, Michigan, United StatesDepartment of Hematology-Oncology, Beaumont Health System, Royal Oak, Michigan, United StatesRecognition of the adverse events of inferior vena cava filters (VCFs) has prompted the Food and Drug Administration (FDA) to issue safety warnings (2010 and 2014), advocating for removal, once the risk of pulmonary embolism has abated. Despite an initial increase in retrieval rates, these remain low (25–30% at 1 year in 2014). We retrospectively investigated retrieval trends in adults with VCFs placed between 2015 and 2018 at a single institution. The rate of retrievable VCF removal accounting for the competing risk of death was the main outcome. There were 494 VCFs placed (305 retrievable). The cumulative incidence of retrieval remained low (21% at 1 year), even after the second FDA warning (2014). Patients who resumed anticoagulation (AC) at any time were more likely to have retrieval (hazard ratio [HR] = 3.6, p < 0.01) and had higher retrieval rates at every time point (31.4 vs. 7.6% at 1 year). Advanced age (HR = 0.98 per year, p = 0.004), stroke (HR = 0.28, p = 0.028), and active malignancy (HR = 0.42, p = 0.006) predicted nonretrieval. Device-related complications were infrequent (<1%) but thrombotic complications occurred early and were more common for nonretrieved VCFs (17 vs. 12%, p = 0.29). Revision of guidelines to recommend active surveillance for the ability to tolerate AC in the immediate postimplantation period may improve retrieval rates.http://www.thieme-connect.de/DOI/DOI?10.1055/s-0040-1722707ivc filterretrievalthrombosisfilter failurepractice trends
spellingShingle Filip Ionescu
Nwabundo Anusim
Eva Ma
Lihua Qu
LeAnn M. Blankenship
Michael Stender
Ishmael Jaiyesimi
Inferior Vena Cava Filter Retrieval Trends: A Single-Center Experience
TH Open
ivc filter
retrieval
thrombosis
filter failure
practice trends
title Inferior Vena Cava Filter Retrieval Trends: A Single-Center Experience
title_full Inferior Vena Cava Filter Retrieval Trends: A Single-Center Experience
title_fullStr Inferior Vena Cava Filter Retrieval Trends: A Single-Center Experience
title_full_unstemmed Inferior Vena Cava Filter Retrieval Trends: A Single-Center Experience
title_short Inferior Vena Cava Filter Retrieval Trends: A Single-Center Experience
title_sort inferior vena cava filter retrieval trends a single center experience
topic ivc filter
retrieval
thrombosis
filter failure
practice trends
url http://www.thieme-connect.de/DOI/DOI?10.1055/s-0040-1722707
work_keys_str_mv AT filipionescu inferiorvenacavafilterretrievaltrendsasinglecenterexperience
AT nwabundoanusim inferiorvenacavafilterretrievaltrendsasinglecenterexperience
AT evama inferiorvenacavafilterretrievaltrendsasinglecenterexperience
AT lihuaqu inferiorvenacavafilterretrievaltrendsasinglecenterexperience
AT leannmblankenship inferiorvenacavafilterretrievaltrendsasinglecenterexperience
AT michaelstender inferiorvenacavafilterretrievaltrendsasinglecenterexperience
AT ishmaeljaiyesimi inferiorvenacavafilterretrievaltrendsasinglecenterexperience